Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
25 studies found for:    "Hypopharyngeal Neoplasms"
Show Display Options
Rank Status Study
1 Completed Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA
Conditions: Laryngeal Neoplasms;   Hypopharyngeal Neoplasms
Intervention: Drug: Weekly Carboplatin & Taxol w/concurrent RT
2 Terminated
Has Results
Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
Conditions: Hypopharyngeal Neoplasms;   Laryngeal Neoplasms;   Head and Neck Cancers
Interventions: Device: da Vinci Surgical Robot Platform;   Procedure: Transoral Robotic Surgery
3 Completed A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures
Conditions: OSA;   Oral Disease;   Oropharyngeal Neoplasms;   Hypopharyngeal Neoplasms
Intervention:
4 Active, not recruiting Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Condition: Hypopharyngeal Cancer
Interventions: Drug: neoadjuvant docetaxel/cisplatin/fluorouracil;   Drug: No treatment before definitive CCRT
5 Not yet recruiting Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer
Conditions: Hypopharyngeal Carcinoma;   Laryngeal Carcinoma
Intervention: Other: Pharyngo laryngeal MRI
6 Recruiting Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
Conditions: Oropharyngeal Cancer;   Hypopharyngeal Cancer
Interventions: Drug: docetaxel and cisplatin;   Radiation: IMRT;   Biological: Nimotuzumab
7 Unknown  The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer
Intervention:
8 Completed Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
Conditions: Carcinoma, Squamous Cell;   Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Hypopharyngeal Neoplasms
Intervention:
9 Recruiting Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Conditions: Malignant Neoplasm of Oropharynx Stage III;   Malignant Neoplasm of Larynx Stage III;   Malignant Neoplasm of Hypopharynx Stage III;   Malignant Neoplasm of Oropharynx Stage IVa;   Malignant Neoplasm of Oropharynx Stage IVb;   Malignant Neoplasm of Larynx Stage IV;   Malignant Neoplasm of Hypopharynx Stage IVa;   Malignant Neoplasm of Hypopharynx Stage IVb
Interventions: Radiation: Escalated Dose;   Radiation: Standard Dose
10 Completed
Has Results
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
Conditions: Head and Neck Cancer;   Oropharyngeal Cancer;   Hypopharyngeal Cancer;   Upper Aerodigestive Tract Neoplasms
Intervention: Procedure: da Vinci® Robotic System
11 Unknown  The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer;   Metastasis
Intervention:
12 Unknown  The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis
Conditions: Oral Cancer;   Laryngeal Cancer;   Hypopharyngeal Cancer
Intervention:
13 Completed Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
Conditions: Larynx Cancer;   Hypopharynx Cancer
Interventions: Drug: cetuximab;   Drug: Cisplatin;   Procedure: Radiotherapy 70 Gy, 35 fractions
14 Completed Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma
Conditions: Larynx Cancer;   Hypopharynx Cancer
Intervention: Drug: DOCETAXEL
15 Active, not recruiting IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
Conditions: Oral Cancer;   Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Procedure: IMRT 75 Gy;   Procedure: Conventional radiotherapy 70 Gy;   Drug: concomitant cisplatin
16 Recruiting A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
Conditions: Colorectal Neoplasms;   Urologic Neoplasms;   Urologic Diseases;   Nasopharyngeal Neoplasms;   Oropharyngeal Neoplasms;   Oral Neoplasms;   Hypopharyngeal Neoplasms;   Laryngeal Neoplasms;   ENT Diseases
Intervention: Procedure: Robotic single port surgery and NOTES
17 Active, not recruiting A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
Conditions: Oropharyngeal Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer
Intervention: Drug: Cetuximab
18 Terminated Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Stage I Hypopharyngeal Cancer;   Stage I Laryngeal Cancer;   Stage I Oropharyngeal Cancer;   Stage II Hypopharyngeal Cancer;   Stage II Laryngeal Cancer;   Stage II Oropharyngeal Cancer;   Stage III Hypopharyngeal Cancer;   Stage III Laryngeal Cancer;   Stage III Oropharyngeal Cancer;   Stage IV Hypopharyngeal Cancer;   Stage IV Laryngeal Cancer;   Stage IV Oropharyngeal Cancer
Interventions: Behavioral: exercise intervention;   Other: questionnaire administration;   Procedure: quality-of-life assessment
19 Terminated Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Oropharynx Cancer;   Larynx Cancer;   Hypopharynx Cancer
Intervention: Drug: Motexafin Gadolinium Injection
20 Recruiting Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Conditions: Carcinoma, Squamous Cell of Head and Neck;   HPV Positive Oropharyngeal Squamous Cell Carcinoma;   Hypopharyngeal Cancer;   Early Invasive Cervical Squamous Cell Carcinoma;   Carcinoma of Larynx;   Cancer of Nasopharynx
Interventions: Drug: BKM120;   Drug: Cisplatin;   Radiation: Intensity-modulated radiotherapy (IMRT)

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.